Profiling Parkinson's Disease

Parkinson's disease is a progressive, neurodegenerative disorder that affects both motor and cognitive function. The etiology of the disease is mostly unknown, but it probably involves both environmental and genetic. This feed focuses on profiling and defining Parkinson’s disease using biological and computational methods.

January 17, 2021
Open Access

Inhibition of mitochondrial complex II in neuronal cells triggers unique pathways culminating in autophagy with implications for neurodegeneration.

Scientific Reports
Sathyanarayanan RanganayakiMuchukunte Mukunda Srinivas Bharath
January 19, 2021
Open Access

Metabolomic analysis data of MPP+ -exposed SH-SY5Y cells using CE-TOFMS

Data in Brief
Taku AmoNobutaka Hattori
January 21, 2021

Pharmacological validation of TDO as a target for Parkinson's disease.

The FEBS Journal
Paula Perez-PardoAletta D Kraneveld
January 25, 2021
Open Access

Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.

Molecular Neurodegeneration
Yaping ShaoWeidong Le
January 19, 2021
Review

Recent advances in enzymeless-based electrochemical sensors to diagnose neurodegenerative diseases

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Zeyu SongXiaoying Tang
January 16, 2021
Review

Brain lipidomics as a rising field in neurodegenerative contexts: Perspectives with Machine Learning approaches

Frontiers in Neuroendocrinology
Daniel Báez CastellanosJanneth González Santos
December 24, 2020
Review

Skin Metabolomics

Trends in Endocrinology and Metabolism : TEM
Decibel P ElpaPawel L Urban
January 16, 2021

The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Milan ZimmermannKathrin Brockmann
January 15, 2021
Open Access

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease

Scientific Reports
Gabriella HernadiGabor Perlaki
January 19, 2021

Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Nicole Mercado FischerGregory M Pontone
January 18, 2021

Step length synergy while crossing obstacles is weaker in patients with Parkinson's disease.

Gait & Posture
Satyajit AmbikeFabio A Barbieri
January 23, 2021
Open Access

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders.

Brain Sciences
Vasilios C ConstantinidesElisabeth Kapaki
January 17, 2021
Open Access

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease

International Journal of Molecular Sciences
Laura Marsal-GarcíaKatrin Beyer
January 19, 2021

[Development of early diagnosis of Parkinson's disease based on the search for biomarkers such as premotor symptoms and changes in blood].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
E I GusevM V Ugrumov

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/profiling-parkinsons-disease/2811fd14-a503-4d8d-a3c8-d074ace413bd